Petrovax Pharm
Ilya Solovyov has diverse work experience in the electrical engineering field. Ilya began their career as an Electric Meter Test Technician at PAO "Rosseti" from September 2015 to June 2017, where they conducted instrument checks of metering devices and supervised team members' compliance with safety requirements.
Ilya then worked as the Chief Power Engineer at Solnechnye Produkty from June 2017 to March 2019, where they ensured the uninterrupted functioning of electric power equipment and managed subordinate personnel in various departments.
In 2019, Ilya joined SpecEnergoGroup, LLC as the Head of the Department of Electrical Networks Maintenance. Their responsibilities included organizing the work of temporary power supply facilities at construction sites and ensuring compliance with regulatory documents.
Afterwards, they worked as a Sales Support Engineer at Crystel Systems, LLC from October 2019 to March 2021, providing support in sales activities.
Currently, Ilya is employed at Petrovax Pharm since March 2021. Ilya started as an Electric Engineer and later became the Head of the Electrical Supply Department. Their role involves maintenance and repair of electrical installations, as well as ensuring uninterrupted power supply to pharmaceutical production processes.
Overall, Ilya Solovyov has gained valuable experience in managing electrical supply departments, maintenance of electrical equipment, and ensuring smooth operations in pharmaceutical and construction environments.
Ilya Solovyov obtained an Engineer's degree in Electrification and Automation of Agriculture from Saratov State Agrarian University named after N.I.Vavilov. Ilya completed their education at the university from 2009 to 2014.
This person is not in any teams
Petrovax Pharm
Petrovax is a Russian full-cycle biopharmaceutical company with a 20-year successful experience of operating in the pharma market. It is a Top-5 immunobiological manufacturer in Russia. The product portfolio includes its own original pharmaceutical products and vaccines, generics, and localized products by lead pharma companies. The company has an in-house R&D Center and invests heavily into R&D, which provides for launching and marketing in-demand pharmaceuticals and vaccines. Petrovax holds more than 20 new molecule and manufacturing process patents. The company has a certified vivarium with four types of laboratory animals used for clinical trials of own pharmaceutical products and providing CRO services. The company’s manufacturing processes fully comply with the applicable GMP standards and ISO:9001. Petrovax’s pharmaceutical manufacturing complex located in Moscow Region is one of the most high-tech biopharmaceutical facilities in Russia providing for manufacturing 160M shots of pharmaceutical products a year. The operations range from API synthesis to manufacturing a variety of dosage forms such as prefilled syringes, ampoules, vials, tablets, and suppositories. Petrovax is the first in Russia immunobiological manufacturer to be issued international GMP certificates by the EU and Iran’s authorities. The company has a proven record of implementing international technology transfer projects related to full-cycle manufacturing, control, and quality assurance for immunobiological products. Petrovax’s partners are the world’s leading pharma companies such as Pfizer, Abbott, and Boehringer Ingelheim. Presently, the company is successfully competing with the world’s industry leaders both in the domestic and foreign markets exporting its products to the EEU, Middle East (Iran), and EU (Slovakia). The prospective export areas are the South-Eastern Europe, Egypt and other MENA countries. Petrovax has more than 600 skilled employees. It is an Interros Group company.